Hormone therapy represents 62.4% of the product type category and oral administration accounts for 58.8% of route of administration demand in 2025. The menopause treatment market was valued at USD 799 million in 2025, is projected to reach USD 1.38 billion by 2035 and is forecast to post a 5.6% CAGR between 2025 and 2035.